4-Nitroimidazole - CAS 3034-38-6
Catalog: |
BB020558 |
Product Name: |
4-Nitroimidazole |
CAS: |
3034-38-6 |
Synonyms: |
5-nitro-1H-imidazole; 5-nitro-1H-imidazole |
IUPAC Name: | 5-nitro-1H-imidazole |
Description: | An impurity of Metronidazole. Metronidazole is an antibacterial in the treatment of rosacea. Antiprotozoal (trichomonas). A potential human carcinogen. |
Molecular Weight: | 113.07 |
Molecular Formula: | C3H3N3O2 |
Canonical SMILES: | C1=C(NC=N1)[N+](=O)[O-] |
InChI: | InChI=1S/C3H3N3O2/c7-6(8)3-1-4-2-5-3/h1-2H,(H,4,5) |
InChI Key: | VYDWQPKRHOGLPA-UHFFFAOYSA-N |
Boiling Point: | 404.8 °C at 760 mmHg |
Melting Point: | >270 °C (dec.) |
Purity: | > 95 % |
Density: | 1.552 g/cm3 |
Appearance: | Off-white solid |
MDL: | MFCD00005196 |
LogP: | 0.84110 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2015017856-A1 | Article including intumescent coating, process for forming and use of same | 20140806 |
WO-2015189636-A1 | Methods and compositions for preparing sequencing libraries | 20140613 |
WO-2015171641-A1 | Coordinate control of pathogenic signaling by the mir-130/301 family in pulmonary hypertension and fibroproliferative diseases | 20140505 |
US-2015328292-A1 | Caspase polypeptides having modified activity and uses thereof | 20140307 |
WO-2015134877-A1 | Caspase polypeptides having modified activity and uses thereof | 20140307 |
PMID | Publication Date | Title | Journal |
25070100 | 20141001 | Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects | Antimicrobial agents and chemotherapy |
22677132 | 20121123 | Disrupted intracellular redox balance of the diplomonad fish parasite Spironucleus vortens by 5-nitroimidazoles and garlic-derived compounds | Veterinary parasitology |
23122401 | 20121101 | Simultaneous determination of morinidazole, its N-oxide, sulfate, and diastereoisomeric N(+)-glucuronides in human plasma by liquid chromatography-tandem mass spectrometry | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences |
22998258 | 20120921 | Experimental and theoretical studies of the decomposition of new imidazole based energetic materials: model systems | The Journal of chemical physics |
22539226 | 20120901 | Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness) | Mutagenesis |
Complexity: | 99.2 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 113.022526347 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 113.022526347 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 74.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Imidazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS